[Therapeutic measures in angina pectoris vera].
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D000787:Angina Pectoris / Q000188:drug therapy / Q000628:therapy*; D004035:Diet Therapy; D004359:Drug Therapy, Combination; D006801:Humans; D009574:Nitro Compounds / Q000009:adverse effects / Q000627:therapeutic use; D005996:Nitroglycerin / Q000009:adverse effects / Q000627:therapeutic use; D010806:Physical Education and Training; D026741:Physical Therapy Modalities; D012146:Rest; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D009574:Nitro Compounds; D014665:Vasodilator Agents; D005996:Nitroglycerin
Therapeutisches Vorgehen bei Angina pectoris vera